Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.158 USD | +5.27% | +3.67% | -33.84% |
12/04 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
02/04 | Vaccinex, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration- Stock Market
- Equities
- VCNX Stock
- News VACCINEXPAR
- Vaccinex Reports Positive Interim Data From Study of Pepinemab, Keytruda Combination to Treat Head, Neck Cancer